SBH Sciences
Dr. Tami Rashal currently serves as the Chief Medical Officer at SBH Sciences and has founded and leads Merlin Health as CEO. With extensive experience in medical advisory roles, Dr. Rashal has held senior medical advisor positions at BiVictriX Therapeutics plc, Sporos Bioventures, and Polaroid Therapeutics. Dr. Rashal holds a Master of Business Administration in Health/Health Care Administration/Management from the Sofaer Global MBA program at Tel Aviv University, completed in July 2021, and a medical degree from Semmelweis University, earned between 1997 and 2002.
This person is not in any teams
This person is not in any offices
SBH Sciences
SBH Sciences is an innovative preclinical contract research organization focused on anti-cancer and anti-inflammation drug development.